Covered recipient · General Payments record
JASEN KOBOBEL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$4,944.80
- Reported across 304 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $677.16 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $493.67 | 20 |
| Novo Nordisk AS | $64.91 | 3 |
| Exact Sciences Corporation | $37.30 | 2 |
| Mylan Specialty L.P. | $23.41 | 1 |
| PFIZER INC. | $21.86 | 1 |
| Acerta Pharma LLC | $20.81 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.10 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104090800 | CMS |
| ABBVIE INC. | $25.97 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104090802 | CMS |
| ABBVIE INC. | $19.66 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104090804 | CMS |
| ABBVIE INC. | $27.21 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104090806 | CMS |
| ABBVIE INC. | $25.77 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104090808 | CMS |
| ABBVIE INC. | $22.48 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104090810 | CMS |
| ABBVIE INC. | $28.06 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104090812 | CMS |
| ABBVIE INC. | $25.97 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104090814 | CMS |
| ABBVIE INC. | $28.33 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104090816 | CMS |
| ABBVIE INC. | $23.96 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104090818 | CMS |
| ABBVIE INC. | $28.26 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104090820 | CMS |
| ABBVIE INC. | $28.33 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104090822 | CMS |
| ABBVIE INC. | $25.97 | 06/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104090824 | CMS |
| ABBVIE INC. | $22.06 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104090826 | CMS |
| ABBVIE INC. | $24.99 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104090828 | CMS |
| ABBVIE INC. | $26.26 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104090830 | CMS |
| ABBVIE INC. | $26.26 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104090832 | CMS |
| ABBVIE INC. | $25.97 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104090834 | CMS |
| ABBVIE INC. | $9.16 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104090836 | CMS |
| ABBVIE INC. | $23.90 | 11/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104090838 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.81 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104251167 | CMS |
| Exact Sciences Corporation | $19.75 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114738785 | CMS |
| Exact Sciences Corporation | $17.55 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114738791 | CMS |
| Mylan Specialty L.P. | $23.41 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147353608 | CMS |
| Novo Nordisk Inc | $18.98 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096749317 | CMS |
| Novo Nordisk Inc | $23.85 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096619726 | CMS |
| Novo Nordisk Inc | $22.08 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097775361 | CMS |
| PFIZER INC. | $21.86 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131621792 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.20 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153622323 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.